Unravelling the true value of generic medicines; IQVIA report

For the last three decades, the availability of cost-effective generic medicines has driven increased access to life-saving treatments for millions of patients in Europe. Today, these medicines are an integral part of the healthcare system, says leading analytics firm IQVIA.

While the increased use has led to unprecedented savings for healthcare systems, the focus of policy is on their cost saving potential, underplaying the true value of generic medicines to society. This neglect of their full contribution can exacerbate the challenges that healthcare systems are facing today.

The newly published study from IQVIA, titled “ Beneath the Surface: Unravelling the True Value of Generic Medicines,” explores the contribution of generic medicines to European health systems, through an examination of their critical role in increasing access, financial sustainability, supply chain resilience and better outcomes for patients.